Paid Clinical Trials in Walnut Creek, CA
As of August 2026, 179 paid clinical trials are recruiting in Walnut Creek, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Walnut Creek offers studies at sites including Kaiser Permanente-Walnut Creek for conditions such as Obesity, Overweight, Major Depressive Disorder, Alzheimer Disease. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Walnut Creek
Trials by drug in Walnut Creek
Filter results
Newly added in Walnut Creek
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
170 clinical trials
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
A Study of Brenipatide in Adult Participants With Schizophrenia
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Top Research Study Locations in Walnut Creek
Researchers run research studies in Walnut Creek, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Kaiser Permanente-Walnut Creek | Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 | 30 |
| Sunwise Clinical Research | Major Depressive Disorder, Acute Migraine, Acute Treatment of Migraine | 19 |
| Diablo Clinical Research, Inc. | Obesity, Overweight, Clostridioides Difficile Associated Disease | 15 |
| Diablo Clinical Research | Obesity, Overweight, Type 1 Diabetes Mellitus | 8 |
| John Muir Medical Center-Walnut Creek | Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Ann Arbor Stage I Lymphoma | 7 |
| BASS Medical Group - Lennon | Malignant Solid Neoplasm, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 6 |
| Bay Area Retina Associates | Age - Related Macular Degeneration (AMD), DME, Diabetic Macular Edema | 6 |
| John Muir Health | Non Small Cell Lung Cancer, Acute Stroke, Aneurysmal Subarachnoid Hemorrhage (aSAH) | 6 |
| Kaiser Permanente Walnut Creek Medical Center | Antibiotic Stewardship, Carcinoma, Non-Small-Cell Lung, Chronic Lymphocytic Leukemia | 5 |
| ADARx Clinical Site | HAE, Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2 | 3 |
| BASS Cancer Center | Carcinoma, Non-Small-Cell Lung, Drug-Related Side Effects and Adverse Reactions, Nausea | 3 |
| Bay Area Retina Associates - Walnut Creek | Diabetic Macular Edema, Geographic Atrophy Secondary to Age-related Macular Degeneration | 2 |
| Boomerang Healthcare | Chronic Pain, Lumbar Disc Disease | 2 |
| Diablo Clinical Research, LLC dba Flourish Research | Body Weight, COVID-19 Vaccines, Nutrition Disorders | 2 |
| Epic Care Cyberknife Center | Acral Lentiginous Melanoma, Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 | 2 |
| GSK Investigational Site | Chickenpox, Measles, Measles-Mumps-Rubella+Chickenpox Vaccine | 2 |
| Kaiser Permanente - Walnut Creek Medical Center | Advanced Solid Tumors, Cutaneous Melanoma, Stage II, Lymphoma, Non-Hodgkin | 2 |
| Kaiser Permanente Walnut Creek | Breast Neoplasms, Clostridioides Difficile Associated Disease, Neoplasm Metastasis | 2 |
| Sunwise Clinical Research, LLC - Walnut Creek - IVY - PPDS | Psychosis Associated With Alzheimer's Disease | 2 |
| Sunwise Clinical Research, Llc | Depression, Major Depressive Disorder (MDD), Major Depressive Episode (MDE) | 2 |
| Vanda Investigational Site | Major Depressive Disorder (MDD), Schizophrenia | 2 |
| Bass Medical Group | Lymphoma, Large B-Cell, Diffuse, DLBCL, Diffuse Large B-Cell Lymphoma | 2 |
| John Muir Health Cancer Center | Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer | 2 |
| 2121 N. California Blvd., Suite 310 | Heart Failure | 1 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
Active & Upcoming Studies in Walnut Creek (2026)
Recruiting trials in Walnut Creek grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (63 active studies)
- A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202) · Phase 3 · Bristol-Myers Squibb
- Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2 · Phase 3 · AstraZeneca
Diabetes & metabolic (22 active studies)
Neurology & pain (18 active studies)
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Eye & vision (11 active studies)
- A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated · Phase 1, Phase 2 · Boehringer Ingelheim
- A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME) · Phase 1 · Genentech, Inc.
Mental health & behavior (9 active studies)
- A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD) · Phase 2 · Tonix Pharmaceuticals, Inc.
- A Study of Brenipatide in Adult Participants With Schizophrenia · Phase 2 · Eli Lilly and Company
Cardiovascular (5 active studies)
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
- Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension · Phase 2 · Vanda Pharmaceuticals
Pediatric (3 active studies)
- Vancomycin Reduction Practices (VRP) in the NICU · Children's Hospital of Philadelphia
- CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) · Phase 1, Phase 2 · COUR Pharmaceutical Development Company, Inc.
Vaccines (2 active studies)
- A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age · Phase 4 · BioNTech SE
- A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age · Phase 3 · GlaxoSmithKline
Common conditions studied in Walnut Creek
- Obesity (13 active studies)
- Overweight (10 active studies)
- Major Depressive Disorder (6 active studies)
- Alzheimer Disease (5 active studies)
- Hereditary Angioedema (HAE) (4 active studies)
- Migraine (4 active studies)
Leading research sponsors in Walnut Creek
- National Cancer Institute (NCI)
- Eli Lilly and Company
- Pfizer
- AbbVie
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Walnut Creek?
There are approximately 179 recruiting clinical trials in Walnut Creek, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Walnut Creek pay participants?
Most recruiting trials in Walnut Creek compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Walnut Creek?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Walnut Creek?
The most common conditions under active study in Walnut Creek include Obesity (13), Overweight (10), Major Depressive Disorder (6), Alzheimer Disease (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Walnut Creek?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Walnut Creek on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Walnut Creek?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Walnut Creek?
Recruiting research sites in Walnut Creek include Kaiser Permanente-Walnut Creek, Sunwise Clinical Research, Diablo Clinical Research, Inc., among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Walnut Creek right now?
The largest active categories in Walnut Creek are Cancer & tumors (63), Diabetes & metabolic (22), Neurology & pain (18). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.